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1. Introduction 
Studies of the permeability properties of mito- 
chondria indicate that the cristae membrane con- 
tains several systems used for the transport of sub- 
strates into and from the matrix space, including a 
dicarboxylic acid transporter system [ 1,2] . The dis- 
covery of some inhibitors of these systems [3-71 has 
enabled progress to be made in understanding their 
chemical nature and the reactions that they catalyse 
PI . 
This communication describes the inhibition of 
succinate oxidation by some metal-complexing agents 
and presents evidence that their site of action is si- 
tuated in the dicarboxylic acid transporter system. 
The results suggest hat a metal ion may be an essen- 
tial component of this transporter system. 
2. Materials and methods 
Sodium bathophenanthroline sulphonate and tannic 
acid were obtained from the Sigma Chemical Company. 
Butylmalonate (Aldrich Chemical Company) was a 
gift from Dr. R.B.Beechy. Other reagents were ob- 
tained from Hopkin and Williams Ltd. 
Rat liver mitochondria were isolated in 0.25 M 
sucrose by the method of Schneider [8] . Respiration 
rates were measured by the polarographic technique 
with a Clark oxygen electrode [9]. The reaction mix- 
ture (volume 3.2 ml) contained 0.25 M sucrose, 15 mM 
KCl, 5 mM MgC12, 8 mM K phosphate buffer and 2 pg 
of rotenone, at pH 7.4 and 25”, together with mito- 
chondria (4.5 mg of protein) and various concentra- 
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tions of K succinate and inhibitor as indicated. Respi- 
ration was stimulated by the addition of either 0.6 
mM ADP or 0.1 mM 2,4-dinitrophenol (DNP). 
The extinction at 750 nm due to light-scattering of 
mitochondrial suspension was measured in a dual- 
wavelength scanning spectrophotometer (Phoenix Pre- 
cision Instruments, Philadelphia, Pa., U.S.A.). A 
decrease in extinction was assumed to be due to mito- 
chondrial swelling. The reaction mixture (volume 
3.0 ml) contained 80 mM ammonium succinate, 5 mM 
tris-HCl buffer, 0.1 mM EGTA, 4 pg of antimycin and 
4 pg of rotenone, at pH 7.4 and 25”, together with 
mitochondria (3’.0 mg of protein) and various concen- 
trations of inhibitor as indicated. Swelling was stimu- 
lated by the addition of 3 mM ammonium phosphate. 
3. Results and discussion 
The addition of bathophenanthroline sulphonate to 
a suspension of liver mitochondria oxidizing succinate, 
in the presence of either ADP and phosphate or 
2,4-dinitrophenol, caused an immediate inhibition of 
respiration (fig. 1). Since bathophenanthroline was an 
equally effective inhibitor of both phosphorylating 
and uncoupled respiration, the inhibition appeared 
to be situated at the respiratory-chain level, and not 
in the phosphorylation system. The inhibition of un- 
coupled succinate oxidation by a fixed concentration 
of inhibitor was decreased when the succinate con- 
centration was increased, suggesting that bathophen- 
anthroline was acting as a competitive inhibitor. This 
conclusion was confirmed by measurements of the 
effect of bathophenanthroline concentration on the 
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Fig. 1. Effect of bathophenanthroline sulphonate concentra- 
tion on the rate of succinate oxidation stimulated by ADP or 
DNP. The succinate concentration was 5 mM. 
rate of succinate oxidation at various substrate con- 
centrations. The data obtained are presented in the 
form of double reciprocal plots (fig. 2). The K,,, for 
succinate in the absence of inhibitor (0.48 mM) was 
increased to 9 mM in the presence of 0.3 mM batho- 
phenanthroline, but no change was observed in the 
value of V,,. Palmer [lo] concluded that the in- 
hibition of coupled succinate oxidation by 5 mM 
bathophenanthroline sulphonate was due to an action 
on the phosphorylation system and not at the respi- 
ratory-chain level. In his interesting experiments, the 
competitive inhibition of succinate oxidation by 
bathophenanthroline sulphonate was probably over- 
come by the high concentration of succinate (100 
mM) that he used, thus enabling an inhibition of the 
phosphorylation system to be observed. 
The inhibition of uncoupled succinate oxidation 
by bathophenanthroline (fig. 1) was also decreased 
by the addition of cytochrome c (0.2 I.tmoles/g of pro- 
tein) with a membrane-lytic concentration of Triton 
X-100 (0.02%, v/v). Bathophenanthroline sulphonate 
had no significant effect on succinate oxidation when 
the mitochondrial suspension was sonicated before 
assay. These observations suggested that the action of 
the inhibitor was on the entry of succinate via the di- 
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Fig. 2. Double reciprocal plots of the rate of succinate oxida- 
tion (DNP-stimulated) against succinate concentration in the 
presence of various concentrations of bathophenanthroline 
sulphonate as indicated. 
carboxylic acid transporter, and not on the succinate 
oxidation system. Succinate transport into mitochon- 
dria was therefore investigated by studying the swel- 
ling of mitochondria in solutions of ammonium suc- 
cinate containing a low concentration of ammonium 
phosphate [l] . Mitochondrial swelling in ammonium 
succinate (or ammonium malate) was inhibited by 
bathophenanthroline sulphonate (fig. 3), thus con- 
firming that this compound is an inhibitor of the 
dicarboxylic acid transporter. 
The inhibition of succinate oxidation by batho- 
phenanthroline was compared with that induced by 
two other inhibitors of the dicarboxylic acid trans- 
porter, namely butylmalonate [3] and ta.nnic acid 
[7] . The data obtained (fig. 4) are presented in the 
form of Dixon plots [ 1 I] . The plot was linear when 
butylmalonate was the inhibitor used, in agreement 
with the conclusion [3] that this reagent is a true 
competitive inhibitor. In contrast, the plots obtained 
with tannic acid and bathophenanthroline sulphonate 
were non-linear, indicating that these reagents are 
partially competitive inhibitors [ 121 and do not act 
directly at the succinate binding site. 
We have found that other metal-complexing agents, 
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Fig. 3. Effect of bathophenanthroline sulphonate concentra- 
tion on the initial rate of phosphate-induced swelling of mito- 
chondria suspended in ammonium succinate. 
BATHOPHENANTHROLINE 
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Fig. 4. Dixon plots of the inhibition of succinate oxidation. 
The succinate concentration was 5 mM. The concentrations 
of inhibitor solutions used were: butylmalonaje, 0.5 M; batho- 
phenanthroline sulphonate, 20 mM; tannic acid, 2.5 mM. Ali- 
quots of these inhibitor solutions were added to the reaction 
mixture as indicated. 
including bathocuproine, o-phenanthroline, 
8-hydroxyquinoline and tiron (catechol disulphonic 
acid) also act as competitive inhibitors of uncoupled 
succinate oxidation. The fact that several chemically 
distinct metal-complexink reagents exert a similar inhi- 
bitory action stiggests that their effects are due to their 
common metal-complexing activity. Some of the re- 
agents have strong affinities for ferrous ions, but they 
also form complexes with a number of other metals 
[ 131. It is therefore postulated that the reagents form 
a complex with a metal ion, possibly non-haem iron, 
which is involved in the mechanism of anion exchanges 
catalysed by the dicarboxylic acid transporter system. 
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